Clincosm LogoSign in Get a demo

b cell leukemia

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • CD19 specific Chimeric Antigen Receptor T Cell
  • Columbus, Ohio
    Nationwide Children's Hospital
Mar 9, 2023

B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)

Active, not recruiting
  • B Cell Leukemia
  • Autologous CD19 CAR+ EGFTt + T cells
  • Seattle, Washington
    Seattle Children's Hospital
Feb 15, 2022

Development of B-cell Leukemias and Lymphomas in Children of

Not yet recruiting
  • B Cell Leukemia
  • Lymphoma
  • SNP analysis of the DNA
  • (no location specified)
Oct 26, 2021

B Cell Leukemia, B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Guangzhou (CAR-ITNK cells)

Recruiting
  • B Cell Leukemia
  • +4 more
  • CAR-ITNK cells
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Feb 6, 2021

Relapsed Adult ALL, B Cell Leukemia Trial in Chongqing (anti-CD19 allo-CAR-T cells)

Recruiting
  • Relapsed Adult ALL
  • B Cell Leukemia
  • anti-CD19 allo-CAR-T cells
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Nov 12, 2020

B Cell Lymphoma, B Cell Leukemia, Myeloma Trial in Wenzhou (CAR-CD19 T cell, CAR-BCMA T cell, CAR-GPC3 T cell)

Active, not recruiting
  • B Cell Lymphoma
  • +5 more
  • CAR-CD19 T cell
  • +5 more
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Oct 5, 2020

B Cell Leukemia, B Cell Lymphoma Trial in Philadelphia (CART-19)

Completed
Has Results
  • B Cell Leukemia
  • B Cell Lymphoma
  • CART-19
  • Philadelphia, Pennsylvania
    CHOP - http://www.chop.edu/service/oncology/pediatric-cancer-res
Mar 2, 2020

B Cell Lymphoma, B Cell Leukemia Trial in Chengdu, Shanghai (CD20-CD19 cCAR T cells)

Unknown status
  • B Cell Lymphoma
  • B Cell Leukemia
  • CD20-CD19 cCAR T cells
  • Chengdu, China
  • +1 more
Nov 8, 2019

B Cell Lymphoma, B Cell Leukemia Trial in Chengdu, Shenzhen (CD19 CARvac T cells)

Unknown status
  • B Cell Lymphoma
  • B Cell Leukemia
  • CD19 CARvac T cells
  • Chengdu, China
  • +1 more
Nov 8, 2019

Refractory, Relapsed, B Cell Lymphoma Trial in Zhengzhou (CAR-T cells)

Unknown status
  • Refractory
  • +3 more
  • CAR-T cells
  • Zhengzhou, Henan, China
  • +1 more
Mar 19, 2019

B Cell Leukemia Trial in Beijing (donor-derived CD19/22 bispecific CAR-T cells or CD19-directed CAR-T cells; donor-derived-HSCT)

Unknown status
  • B Cell Leukemia
  • donor-derived CD19/22 bispecific CAR-T cells or CD19-directed CAR-T cells; donor-derived-HSCT
  • Beijing, China
    Biotherapeutic Department and Hematology Department of Chinese P
Mar 12, 2018

B Cell Leukemia, B Cell Lymphoma Trial in Weifang (ICAR19 CAR-T cells)

Recruiting
  • B Cell Leukemia
  • B Cell Lymphoma
  • ICAR19 CAR-T cells
  • Weifang, Shandong, China
    Weifang People's Hospital
Dec 19, 2017

B Cell Lymphoma, B Cell Leukemia Trial in Uppsala (Autologous 3rd generation CD19-targeting CAR T cells)

Completed
  • B Cell Lymphoma
  • B Cell Leukemia
  • Autologous 3rd generation CD19-targeting CAR T cells
  • Uppsala, Sweden
    Uppsala University Hospital, Dept of Oncology
Oct 27, 2017